Newly Diagnosed Childhood AML Patients Treated with Bortezomib Show Superior Survival If CD74 Is Expressed: A Report of 991 Patients from the Children's Oncology Group AAML1031 Protocol

MLA

Robert B. Gerbing, et al. “Newly Diagnosed Childhood AML Patients Treated with Bortezomib Show Superior Survival If CD74 Is Expressed: A Report of 991 Patients from the Children’s Oncology Group AAML1031 Protocol.” Blood, vol. 136, Nov. 2020, p. 39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........26fe783d8eb5b478a4ef057055146d24&authtype=sso&custid=ns315887.

APA

Robert B. Gerbing, Michael R. Loken, Laura Pardo, Loren L. Lott, Jessica A. Pollard, Richard Aplenc, E. Anders Kolb, Lisa Eidenschink Brodersen, Chad A. Hudson, Timothy P. Singleton, Todd M. Cooper, Soheil Meshinchi, Fan Chi Hsu, Fangyan Dai, Keely Ghiradelli, Amanda R. Leonti, & Todd A. Alonzo. (2020). Newly Diagnosed Childhood AML Patients Treated with Bortezomib Show Superior Survival If CD74 Is Expressed: A Report of 991 Patients from the Children’s Oncology Group AAML1031 Protocol. Blood, 136, 39.

Chicago

Robert B. Gerbing, Michael R. Loken, Laura Pardo, Loren L. Lott, Jessica A. Pollard, Richard Aplenc, E. Anders Kolb, et al. 2020. “Newly Diagnosed Childhood AML Patients Treated with Bortezomib Show Superior Survival If CD74 Is Expressed: A Report of 991 Patients from the Children’s Oncology Group AAML1031 Protocol.” Blood 136 (November): 39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........26fe783d8eb5b478a4ef057055146d24&authtype=sso&custid=ns315887.